thought leadership

Preparing Pandemic Vaccine Capacity

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently contributed to an editorial in discussing the importance of collaboration between innovators, manufacturing partners, and the entire supply chain when preparing for rapid scale-up of COVID-19 vaccine candidates. 

Read the full article here

Excerpted from editorial titled, "Preparing Pandemic Vaccine Capacity"

The biopharmaceutical industry is working at unprecedented speed to develop and manufacture vaccines for the COVID-19 pandemic. Among the challenges of a pandemic is the need to scale up to billions of doses, at a larger scale than typically needed for vaccines, from raw materials all the way through to the materials for the containers for fill/finish.

Article details

BioPharm International
Vol. 33, No. 9
September 2020
Pages: 10–14


J. Markarian, "Preparing Pandemic Vaccine Capacity," BioPharm International, 33 (9) 2020.

Strategizing for Rapid Changeovers in Biologics Manufacturing

Syed T. Husain, senior vice president and CDMO business unit head at Emergent BioSolutions recently contributed to an editorial...


Editorial: Good Manufacturing Practices: Challenges with Compliance

Dino Muzzin, Senior Vice President, Manufacturing Operations at Emergent, recently contributed to an article in BioPharm...


May 4th Webinar: Rapid Readiness for Pandemic Response

Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...